Citadel Advisors’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.5M Buy
1,504,714
+627,544
+72% +$30.8M 0.01% 1161
2026
Q1
$41.4M Buy
877,170
+678,001
+340% +$33.6M 0.01% 1541
2025
Q4
$9.37M Buy
199,169
+182,175
+1,072% +$8.45M ﹤0.01% 3337
2025
Q3
$714K Buy
+16,994
New +$683K ﹤0.01% 8294
2025
Q2
Sell
-57,468
Closed -$1.91M 15474
2025
Q1
$1.74M Sell
57,468
-88,178
-61% -$2.54M ﹤0.01% 5799
2024
Q4
$4.14M Sell
145,646
-262,787
-64% -$7.07M ﹤0.01% 4275
2024
Q3
$10.7M Buy
408,433
+350,704
+608% +$6.83M ﹤0.01% 2802
2024
Q2
$843K Sell
57,729
-2,280,386
-98% -$32.2M ﹤0.01% 6943
2024
Q1
$34.5M Buy
+2,338,115
New +$32.1M 0.01% 1523

Other funds holding AHR

Citadel Advisors's AHR Position: Q2 2026 in Review

Citadel Advisors increased its American Healthcare REIT (AHR) stake by 72% in Q2 2026, buying an estimated $30.8M and bringing the position to 1,504,714 shares worth $78.5M. The position accounts for 0.01% of the portfolio, ranked #1161.

Citadel Advisors first reported a position in AHR in Q1 2024 and has held it in 9 quarters since. 572 funds tracked by Wall St. Rank hold AHR as of Q2 2026.

  • Citadel Advisors held 1,504,714 shares of American Healthcare REIT worth $78.5M as of Q2 2026.
  • Citadel Advisors bought 627,544 American Healthcare REIT shares in Q2 2026, an estimated $30.8M.
  • American Healthcare REIT made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #1161 holding.
  • Citadel Advisors first reported a position in American Healthcare REIT in Q1 2024 and has held it in 9 quarters since.
  • 572 funds tracked by Wall St. Rank held American Healthcare REIT as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.